Communication skills training program for medical staff in cancer genomic testing: A mixed-methods assessment of an educational initiative.

9017 Background: Cancer genomic testing presents unique communication challenges for medical staff, particularly regarding low treatment access rates, the complex psychological needs of patients, and concerns about germline findings. While communication skills training (CST) has shown promise in oncology settings, it has not yet been specifically applied to genomic testing conversations. This Pfizer Global Medical Grants Initiative 2023 was designed to address this critical educational gap in the implementation of cancer genomic medicine. Methods: A mixed-methods evaluation was conducted of a structured CST program implemented across 10 institutions under Pfizer’s educational initiative framework. The program incorporated SHARE protocol-based training (Fujimori et al . JCO . 2014), role-playing sessions, and specialized modules addressing genomic testing-specific challenges. The quantitative assessment utilized pre- and post-intervention 4-point categorical assessments. The qualitative evaluation employed semi-structured interviews (median duration 12 minutes, range 7-21) analyzed using a modified grounded theory approach until theoretical saturation. Results: Among 251 participants (22% physicians, 37% nurses, 25% other healthcare professionals, 12% administrative staff, 4% others; median experience 9 years, range 0-39), 95% initially reported a psychological burden when explaining genomic testing results. Post-intervention, 94% reported a reduced psychological burden ( p < 0.001, Chi-square), with 84% expressing satisfaction with the training program. An ordinal logistic regression analysis revealed a significantly greater improvement in nurses than in other professionals (OR 3.52, 95%CI 1.88-6.58, p < 0.001). A qualitative analysis of 19 interviews (58% medical staff, 42% patients/families) revealed four major conceptual categories through a constant comparative analysis: 1) multilayered information needs with psychological support requirements, 2) experiential uncertainty in communicating germline findings, 3) perceived competency gaps in genomic counseling, and 4) organizational support needs for sustained practice changes. A thematic analysis identified a strong demand for program continuation and expansion. Conclusions: This educational initiative revealed significant effectiveness in addressing critical communication challenges in cancer genomic medicine. The mixed-methods evaluation provides a robust framework for implementing specialized CST programs in genomic medicine practice. These results will contribute to the evolving landscape of cancer genomic medicine education and support the value of structured, evidence-based educational initiatives in advancing the delivery of precision oncology care.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.9017
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Communication skills training program for medical staff in cancer genomic testing: A mixed-methods assessment of an educational initiative.

Rie Suzuki, Manabu Seino, Takashi Yoshioka, Shuhei Suzuki et al.
Journal of Clinical Oncology
BRCA gene mutations in cancer
article

Communication skills training program for medical staff in cancer genomic testing: A mixed-methods assessment of an educational initiative.

Rie Suzuki, Manabu Seino, Takashi Yoshioka, Shuhei Suzuki, Koshi Takahashi, Yuta Yamada, Ryosuke Kumanishi, Yosuke Saito, Koki Saito, Tadahisa Fukui
article en

Abstract

9017 Background: Cancer genomic testing presents unique communication challenges for medical staff, particularly regarding low treatment access rates, the complex psychological needs of patients, and concerns about germline findings. While communication skills training (CST) has shown promise in oncology settings, it has not yet been specifically applied to genomic testing conversations. This Pfizer Global Medical Grants Initiative 2023 was designed to address this critical educational gap in the implementation of cancer genomic medicine. Methods: A mixed-methods evaluation was conducted of a structured CST program implemented across 10 institutions under Pfizer’s educational initiative framework. The program incorporated SHARE protocol-based training (Fujimori et al . JCO . 2014), role-playing sessions, and specialized modules addressing genomic testing-specific challenges. The quantitative assessment utilized pre- and post-intervention 4-point categorical assessments. The qualitative evaluation employed semi-structured interviews (median duration 12 minutes, range 7-21) analyzed using a modified grounded theory approach until theoretical saturation. Results: Among 251 participants (22% physicians, 37% nurses, 25% other healthcare professionals, 12% administrative staff, 4% others; median experience 9 years, range 0-39), 95% initially reported a psychological burden when explaining genomic testing results. Post-intervention, 94% reported a reduced psychological burden ( p < 0.001, Chi-square), with 84% expressing satisfaction with the training program. An ordinal logistic regression analysis revealed a significantly greater improvement in nurses than in other professionals (OR 3.52, 95%CI 1.88-6.58, p < 0.001). A qualitative analysis of 19 interviews (58% medical staff, 42% patients/families) revealed four major conceptual categories through a constant comparative analysis: 1) multilayered information needs with psychological support requirements, 2) experiential uncertainty in communicating germline findings, 3) perceived competency gaps in genomic counseling, and 4) organizational support needs for sustained practice changes. A thematic analysis identified a strong demand for program continuation and expansion. Conclusions: This educational initiative revealed significant effectiveness in addressing critical communication challenges in cancer genomic medicine. The mixed-methods evaluation provides a robust framework for implementing specialized CST programs in genomic medicine practice. These results will contribute to the evolving landscape of cancer genomic medicine education and support the value of structured, evidence-based educational initiatives in advancing the delivery of precision oncology care.

Journal of Clinical OncologyVol. 43(16_suppl)
Yamagata University (JP), Tokyo Medical University (JP)
Openalex Percentile: Top 86%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.